[ORGANIZATION]
Recorlev
Featured in 1 tracked story · first seen
Situations
Xeris Biopharma financial performance and analyst updates
2 clusters · 12 sources · last updated
Latest: Global corporations report varied financial results amid AI and tech shifts
Xeris Biopharma reported significant growth in its Recorlev revenue, which rose 81% year-over-year to approximately $56.8 million in the second quarter of 2026. The company also received a U.S. patent notice for Keveyis,